Stay updated on Zimura vs Sham in STGD1: Clinical Trial
Sign up to get notified when there's something new on the Zimura vs Sham in STGD1: Clinical Trial page.

Latest updates to the Zimura vs Sham in STGD1: Clinical Trial page
- CheckyesterdayChange DetectedThe page footer revision tag was updated from v3.5.4 to v3.5.5, indicating a recent update to the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a maintenance update to the entry. It does not change the study content, criteria, or results; it is a version bump.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page’s displayed build/version marker has been incremented from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site release rather than a study-data update.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded links to the results and plain-language summary on external sites. Updated revision from v3.5.0 to v3.5.2.SummaryDifference0.4%

- Check65 days agoChange DetectedAdded a Genetic and Rare Diseases Information Center resources entry, including Severe early-childhood-onset retinal dystrophy.SummaryDifference0.1%

- Check79 days agoChange DetectedResults were posted on 2026-03-12 for the study, detailing outcomes such as mean rate of change in the ellipsoid zone defect and changes in BCVA and macular sensitivity through Month 18. The results section also reports adverse events and other safety-related measurements collected up to 18 months.SummaryDifference3%

Stay in the know with updates to Zimura vs Sham in STGD1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimura vs Sham in STGD1: Clinical Trial page.